Transient versus Persistent BK Viremia and Long-Term Outcomes after Kidney and Kidney-Pancreas Transplantation

被引:69
|
作者
Elfadawy, Nissreen [1 ]
Flechner, Stuart M. [1 ]
Schold, Jesse D. [2 ]
Srinivas, Titte R. [4 ]
Poggio, Emilio [1 ]
Fatica, Richard [1 ]
Avery, Robin [5 ]
Mossad, Sherif B. [3 ]
机构
[1] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA
[2] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA
[3] Cleveland Clin, Dept Infect Dis, Inst Med, Cleveland, OH 44106 USA
[4] Med Univ S Carolina, Div Nephrol, Charleston, SC 29425 USA
[5] Johns Hopkins Univ, Div Infect Dis, Baltimore, MD USA
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2014年 / 9卷 / 03期
关键词
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY; RENAL-TRANSPLANTATION; VIRUS NEPHRITIS; VIRAL LOAD; RECIPIENTS; INFECTION; ALLOGRAFT; REPLICATION; PCR;
D O I
10.2215/CJN.08420813
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives The objective was to study the long-term impact of transient versus persistent BK viremia on kidney transplant outcomes. Design, setting, participants, & measurements In total, 609 recipients who underwent kidney transplant from 2007 to 2011 were screened at months 1-12 for the occurrence of polyomavirus BK viremia; 130 patients (21.7%) developed BK viremia during the first year post-transplant. BK viremia patients were classified according to duration of infection (more or less than 3 months), and BK viral loads (more or less than 10,000 copies/ml) were classified as transient low viremia (n=42), transient high viremia (n=18), persistent low viremia (n=23), and persistent high viremia (n=47). All patients were followed a median of 36 (3-66) months. The rates of BK polyomavirus-associated nephropathy, acute rejection, and 1-year graft function were compared with the polyomavirus BK-negative control group. Results Patient and graft survival were not significantly different among the groups. Graft function (creatinine; milligrams per deciliter) at 1 year was significantly worse in the persistent high viremia (1.75 +/- 0.6) and transient high viremia (1.85 +/- 0.7) groups compared with aviremic controls (1.47 +/- 0.4; P=0.01 and P=0.01, respectively). The incidence of BK polyomavirus-associated nephropathy was limited to the persistent high viremia group (1.3%, P<0.001). The transient high viremia (50%) and persistent high viremia (34%) groups showed significantly (P=0.01) increased incidence of acute rejection versus aviremic controls (21.5%), transient low viremia (19%), or persistent low viremia (17.3%) groups. Conclusion Low viral load BK viremia, either transient or persistent, was not associated with long-term transplant outcomes. Persistent high viremia was associated with a greater risk for BK polyomavirus-associated nephropathy and subsequent graft dysfunction. Although transient high viremia was not associated with BK polyomavirus-associated nephropathy, it was associated with worse graft function. These data support the role of surveillance for BK viremia after transplant.
引用
收藏
页码:553 / 561
页数:9
相关论文
共 50 条
  • [41] Incidence, risk factors, outcomes, and clinical management of BK viremia in the modern era of kidney transplantation
    Qeska, Denis
    Wong, Rebecca Bic Kay
    Famure, Olusegun
    Li, Yanhong
    Pang, Hilary
    Liang, Xin Yun
    Zhu, Mary Parker
    Husain, Shahid
    Kim, Sang Joseph
    TRANSPLANT INFECTIOUS DISEASE, 2022, 24 (06)
  • [42] Subclinical inflammation phenotypes and long-term outcomes after pediatric kidney transplantation
    Seifert, Michael E.
    Yanik, Megan V.
    Feig, Daniel I.
    Hauptfeld-Dolejsek, Vera
    Mroczek-Musulman, Elizabeth C.
    Kelly, David R.
    Rosenblum, Frida
    Mannon, Roslyn B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 (09) : 2189 - 2199
  • [43] Long-term Allograft Survival After Kidney Transplantation
    Gomez Gomez, E.
    Campos Hernandez, J. P.
    Marquez Lopez, F. J.
    Ruiz Garcia, J.
    Garcia Montemayor, V.
    Anglada Curado, F.
    Leva Vallejo, M.
    Regueiro Lopez, J. C.
    Navarro Cabello, M. D.
    Aljama, P.
    Requena Tapia, M. J.
    TRANSPLANTATION PROCEEDINGS, 2013, 45 (10) : 3599 - 3602
  • [44] Long-Term Follow-Up of Active Treatment Versus Minimization of Immunosuppressive Agents in Patients With BK Virus-Associated Nephropathy After Kidney Transplant
    Halim, Medhat A.
    Al-Otaibi, Torki
    Gheith, Osama
    Mosaad, Ahmed
    Zakaria, Zakaria
    Said, Tarek
    Nair, Prasad
    Nampoory, Narayanan M. R.
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2016, 14 (01) : 58 - 65
  • [45] Long-Term Cancer Risk of Immunosuppressive Regimens after Kidney Transplantation
    Gallagher, Martin P.
    Kelly, Patrick J.
    Jardine, Meg
    Perkovic, Vlado
    Cass, Alan
    Craig, Jonathan C.
    Eris, Josette
    Webster, Angela C.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (05): : 852 - 858
  • [46] Cytomegalovirus infection after kidney transplantation and long-term graft loss
    Ovidia Lopez-Oliva, Maria
    Flores, Julio
    Madero, Rosario
    Escuin, Fernando
    Jose Santana, Maria
    Bellon, Teresa
    Selgas, Rafael
    Jimenez, Carlos
    NEFROLOGIA, 2017, 37 (05): : 515 - 525
  • [47] Antihypertensive pharmacotherapy and long-term outcomes in pediatric kidney transplantation
    Suszynski, Thomas M.
    Rizzari, Michael D.
    Gillingham, Kristen J.
    Rheault, Michelle N.
    Kraszkiewicz, Wojciech
    Matas, Arthur J.
    Chavers, Blanche M.
    CLINICAL TRANSPLANTATION, 2013, 27 (03) : 472 - 480
  • [48] Long-term Outcomes Following Kidney Transplantation From Donors With Acute Kidney Injury
    Heilman, Raymond L.
    Smith, Maxwell L.
    Smith, Byron H.
    Kumar, Anjushree
    Srinivasan, Ananth
    Huskey, Janna L.
    Khamash, Hasan A.
    Jadlowiec, Caroline C.
    Mathur, Amit K.
    Moss, Adyr A.
    Reddy, Kunam S.
    TRANSPLANTATION, 2019, 103 (09) : E263 - E272
  • [49] Clinicopathological Analysis of Persistent Hypercalcemia and Hyperparathyroidism After Kidney Transplantation in Long-Term Dialysis Patients
    Nakamura, Michio
    Tanaka, Kiho
    Marui, Yuhji
    Tomikawa, Shinji
    THERAPEUTIC APHERESIS AND DIALYSIS, 2013, 17 (05) : 551 - 556
  • [50] No clinical benefit of rapid versus gradual tapering of immunosuppression to treat sustained BK virus viremia after kidney transplantation: a single-center experience
    Devresse, Arnaud
    Tinel, Claire
    Vermorel, Agathe
    Snanoudj, Renaud
    Morin, Lise
    Avettand-Fenoel, Veronique
    Amrouche, Lucile
    Scemla, Anne
    Zuber, Julien
    Legendre, Christophe
    Rabant, Marion
    Anglicheau, Dany
    TRANSPLANT INTERNATIONAL, 2019, 32 (05) : 481 - 492